Clinical Trials: An African American Survivor’s Experience Melvin Mann benefited from joining a pivotal clinical trial for chronic myelogenous leukemia, but participation came with logistical challenges. by Melvin Mann Turning Up the Heat on Cancer Researchers are working to expand the benefits of immunotherapy by making “cold” tumors “hot” so they can respond better to treatments. by Kendall K. Morgan FORWARD LOOK Early Chemotherapy Dose Reductions May Affect Breast Cancer Outcomes New study explores impact of lowering dose due to side effects. by Jane Langille FORWARD LOOK Targeted Treatments for Tots New law mandates that cancer drugs get tested in kids in clinical trials. by Sharon Tregaskis FORWARD LOOK What’s Next? Treating prostate cancer with fewer side effects. by Bradley Jones Exploring Immunotherapy for Triple Negative Breast Cancer Following the approval of the first immunotherapy for breast cancer by the U.S. Food and Drug Administration in March 2019, experts at the San Antonio Breast Cancer Symposium discussed avenues for further development. by Marci A. Landsmann Possible New Treatments for Patients With Metastatic HER2-Positive Breast Cancer Studies presented at the San Antonio Breast Cancer Symposium show additional treatment options. by Marci A. Landsmann A Switch From Intravenous to Oral Chemo? Compared with intravenous paclitaxel, the oral form of the chemotherapy drug was associated with improved tumor shrinkage in metastatic breast cancer patients. by Ashley P. Taylor Avoiding Unnecessary Lymph Node Biopsy A study adds to evidence that many patients with ductal carcinoma in situ do not need to have their lymph nodes removed. by Cheryl Platzman Weinstock Learning the Language of Chemotherapy Cancer patients often do not understand words their doctors use while talking about chemotherapy, but a new video series helps explain these terms. by Jen Tota McGivney next Cancer Talk Clinical Trials: An African American Survivor’s Experience Melvin Mann benefited from joining a pivotal clinical trial for chronic myelogenous leukemia, but participation came with logistical challenges. by Melvin Mann Food Insecurity and Cancer After discovering that some patients weren’t able to access the food they needed, a community oncology practice partnered with a local food bank. by Jen Tota McGivney “Congrats! You Have the ‘Good’ Cancer” Many people know thyroid cancer as a cancer type with a relatively good prognosis, but the disease still has profound effects on patients and survivors, writes thyroid cancer survivor Carly Flumer. by Carly Flumer Progress, But Still Room for Improvement The winter 2019/2020 issue of Cancer Today tells the stories of people working to improve privacy protections for patients seeking support online, expand access to genetic testing and boost the efficacy of immunotherapy to benefit more patients. by Kevin McLaughlin More Posts